- This topic has 6 replies, 6 voices, and was last updated 6 months ago by Kristy Bray.
-
AuthorPosts
-
-
April 4, 2023 at 7:35 pm #31206Shauna ProutenParticipantDiabetes Education
What do we know about long term safety of using GLP-1’s?
-
April 18, 2023 at 8:20 pm #31245Linda MirekuParticipantDiabetes Education
I think long term effects will dependent on the individual – such as those with pancreatic and thyroid issues.
-
May 16, 2023 at 6:54 pm #31332Ana NevesParticipantDiabetes Education
Agreed.
-
June 9, 2023 at 3:51 pm #31372Janet WilpstraParticipantDiabetes Education
Google answer:
Data from DURATION-1 demonstrated that continuous HbA1c reductions and weight loss were observed for the patients continuing on the treatment, with no unexpected adverse events. Taken together, these data support GLP-1RAs as a long-term noninsulin treatment option after the failure of oral therapy.We are responsible to monitor for changes in client status…regular DEP visits and bloodwork
-
June 9, 2023 at 3:51 pm #31373Janet WilpstraParticipantDiabetes Education
Google answer:
Data from DURATION-1 demonstrated that continuous HbA1c reductions and weight loss were observed for the patients continuing on the treatment, with no unexpected adverse events. Taken together, these data support GLP-1RAs as a long-term noninsulin treatment option after the failure of oral therapy.We are responsible to monitor for changes in client status…regular DEP visits and bloodwork as well as collaboration with PCP
-
July 18, 2023 at 12:37 am #31423Roshni JohnParticipantDiabetes Education
Mostly considered safe. GI adverse reactions are common but can be minimized with gradual dose titration and eating behavior modification. Ongoing monitoring and evaluation followed by dose adjustments with the patient’s consent based on the patient’s health status would be the clinician’s responsibility.
They are contraindicated in patients with a family history of medullary thyroid carcinoma and/or multiple endocrine neoplasia syndrome type 2, pancreatitis, renal impairment, -
August 15, 2024 at 1:59 pm #32538Kristy BrayParticipantThe Essentials Clinical Resource Tool (Annual)
depending on comorbidities, outcomes may be different for each person. This class is still fairly new.
-
-
AuthorPosts
- You must be logged in to reply to this topic.